We launched COVID Vaccine Facts, a new website with scientific and evidence-based information related to the COVID-19 vaccine development process. More details below, plus a look at the benefits of biotech crops. (663 words, 3 minutes, 18 seconds)
BIO challenges “Most Favored Nation” drug pricing…
It’s another busy day in Washington. In the meantime, we have details on our legal challenge to the Trump administration’s drug pricing plan, as well as a look at a new report on the health impacts of climate change and how sustainable biobased…
BIO's new agenda to promote justice through equity
BIO launched an important new agenda to eliminate racial disparities in the industry and health care delivery. We’ve got the details, in around 670 words, just under 4 minutes.
Today, the last full day of the Trump administration, we take a closer look at the Most Favored Nation drug pricing scheme and what to expect in the coming days in D.C. We also have news from Twist Bioscience that could improve testing for the new COVID-19 variant. (885 words, 4 minutes, 25 seconds)
Good Day BIO is off tomorrow, Wednesday, January 20, for Inauguration Day. We will resume publication on Thursday, January 21. Stay safe, D.C.
We’re ending the week with promising news from Johnson & Johnson and another look at the potential for biotechnology to boost our food supply and the economy. Enjoy the long weekend. (784 words, 3 minutes, 55 seconds)
Good Day BIO is taking a break on Monday, January 18, in honor of Martin Luther King Jr. Day. We will resume publication on Tuesday, January 19.
With mRNA, the future of medicine is happening now. We have the details on Moderna’s mRNA vaccine announcement, as well as what we can do to reduce the risk of food insecurity in the face of climate change. (836 words, 4 minutes, 10 seconds)
Today, we take a closer look at the news that the EPA will issue more exemptions to the biofuels requirements—creating more uncertainty for the industry. We also update you on new vaccine distribution guidelines and where things stand in the vaccine race. (917 words, 4 minutes, 35 seconds)
In the wake of last week’s attack on the U.S. Capitol and democracy, BIO will put all political donations on hold while reassessing criteria for determining which candidates to financially support. Keep reading for the details. We also have biofuels news from the U.S. Supreme Court and several states, and a recap of yesterday’s WuXi Global Forum during JPM Week. (826 words, 4 minutes, 7 seconds)
On Friday, the Justice Department decided not to challenge the injunction blocking the implementation of the “Most Favored Nation” drug reimbursement plan. We have the details and how we got here. We also explain what’s behind last year’s carbon emissions drop, and how you can meet new partners during JPM Week. (837 words, 4 minutes, 11 seconds)
Some good news: brand-name drug prices continue to fall, and the UK is considering smart, science-based policy on gene edited crops and livestock. We also tell you how you can share uplifting stories about people who are making a positive impact on patients and the planet. (747 words, 3 minutes, 44 seconds)
Yesterday was an extraordinary day in American history. BIO staff and colleagues who live and work near the U.S. Capitol are safe. Our thoughts are with the families of the four individuals who lost their lives, and with lawmakers and staff, Capitol Police who ushered them to safety, and the journalists who risked their lives to report from the scene. Below, we have BIO President and CEO Dr. Michelle McMurry-Heath’s statement on the events, and a lot of news. (625 words, 3 minutes)
From Georgia to the U.S. Capitol, it’s a big news day. Meanwhile, over the holidays, a court issued a preliminary injunction blocking Trump’s Most Favored Nation drug reimbursement plan. We also tell you what to expect from Biden’s pick to lead USDA. (890 words, 4 minutes, 30 seconds)
All eyes are on Georgia, where today’s two U.S. Senate runoff elections will determine the balance of power in Washington. In the meantime, we’re looking at why we need a national vaccination plan and what investors are thinking about synthetic biology and gene editing. (777 words, 4 minutes)
